logo
logo

Vistacare Medical Secures €4 Million To Accelerate The Development And Adoption Of Its Solutions For The Management Of Serious And Complex Wounds

Jan 26, 2022•over 3 years ago

Amount Raised

€4 Million

Round Type

seed

Besançon

Description

DTAmedical becomes VistaCare Medical on the occasion of the establishment of its financing gathering more than 4 million euros with Noshaq, Cap Innov'Est, its historical shareholder, BFC Croissance & Innovation, Crédit Agricole Bourgogne Franche-Comté Region, WiSEED and DGO6 (region of Wallonia). These contributions are complemented by a grant from the Bourgogne Franche-Comté Region already announced and the renewed support of BpiFrance. VistaCare Medical is also supported by the life sciences integrator LallianSe.

Company Information

Company

Vista Care Medical

Location

Besançon, Bourgogne-Franche-Comté, France

About

We are pleased to help the company develop its R&D and industrialization activities in the Liège area. Founded in 2010 by François Dufaÿ – healthcare professional and entrepreneur, the startup began the development of VistaCare One® in 2015 with its first seed financing round leading to the CE certification in 2018. Founded in 2010 in the Jura region, VistaCare Medical develops, produces, and commercializes the VistaCare® innovative medical device for the treatment of complex wounds. This new operation will allow VistaCare Medical to fully develop and provide a truly effective solution for the treatment of no-contact wounds" comments Jean-François Rax, investment director, Capital Grand Est. VistaCare Medical has everything it takes to become a major player and its partnership approach in France and Europe is very representative of the LallianSe action at the heart of health ecosystems", adds Julie Rachline, president of LallianSe. VistaCare Medical has BPI Excellence label, Medical Startup Awards Medica 2015 and finalist Prix Gallien Med Startup 2019. VistaCare Medical is an innovative medtech company developing and commercializing medical devices for its unique wound management platform.